Literature DB >> 2420725

[In vitro activity, serum, urine and prostatic adenoma concentrations of ofloxacin in urologic patients with complicated urinary tract infections].

K G Naber, D Adam, R Wittenberger, B Bartosik-Wich.   

Abstract

The minimal inhibitory concentrations (MIC) of ofloxacin against 400 isolates cultured from the urine of urological patients with complicated urinary tract infections (UTI) resulted in an inhibition of 94% (99%) of the gram-negative strains at a concentration of 1 mg/l (2 mg/l) and an inhibition of 59% (100%) of the gram-positive strains at a concentration of 1 mg/l (4 mg/l). According to the MIC 90% values, the corresponding grade of activity was as follows: ciprofloxacin, ofloxacin, norfloxacin, pefloxacin, enoxacin, pipemidic acid, enoxacin and nalidixic acid. After an oral dose of 400 mg of ofloxacin, the mean peak serum concentration of ten patients was 5.5 mg/l. The mean renal excretion during 24 hours was 41%. In ten patients undergoing transurethral resection of the prostate, the median serum concentration was 1.87 mg/l and the median prostatic adenoma tissue concentration 1.20 mg/kg 14.5 to 19 hours after oral administration of 400 mg ofloxacin. Due to the in vitro activity and the concentrations obtained in serum, urine and tissue, ofloxacin appears to be well suited for treatment of complicated UTI.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420725     DOI: 10.1007/bf01645201

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  1 in total

1.  [Diffusion of cefamandole into the prostatic tissue (author's transl)].

Authors:  D Adam; A G Hofstetter; F Eisenberger
Journal:  Med Klin       Date:  1979-02-16
  1 in total
  7 in total

1.  Pharmacokinetics of ofloxacin in patients on haemodialysis treatment.

Authors:  A Dörfler; W Schulz; F Burkhardt; M Zichner
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  Application of ofloxacin in gynaecology.

Authors:  E E Petersen; T S de Isele; K Pelz; N Weiss
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 4.  Pharmacokinetics of ciprofloxacin.

Authors:  T Bergan; A Dalhoff; R Rohwedder
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 5.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

6.  Acute nongonococcal epididymitis. Aetiological and therapeutic aspects.

Authors:  W Weidner; H G Schiefer; C Garbe
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Population Pharmacokinetics of Finafloxacin in Healthy Volunteers and Patients with Complicated Urinary Tract Infections.

Authors:  Max Taubert; Mark Lückermann; Andreas Vente; Axel Dalhoff; Uwe Fuhr
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.